Form D · Venture Capital Fund
HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC
Cary, NC · CIK 0001978468
Offering snapshot reported Dec 15, 2025 · SEC filing
- Reported sold
- $204K Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 11
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2025 | Amendment | $204,000 | No comparison | 11 | SEC filing |
| Oct 20, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 23, 2024 | Amendment | $1,498,775 | $948,775vs May 19, 2023 | 35 | SEC filing |
| May 19, 2023 | Initial | $550,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-561417
Source: Form D, filed Dec 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Michael Harlow | Director |
| John Powell Leachman | Director, Promoter |
| Robert Earl Ross | Director, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
107 Kilmayne Drive Suite B
Cary, NC, 27511
Cary, NC, 27511